Peanut allergy: Emerging concepts and approaches for an apparent epidemic

Journal of Allergy and Clinical Immunology

Volumn 120, Issue 3, 2007, Pages 491-503

  Sicherer, Scott H ^a   Sampson, Hugh A ^a  

^a Elliot and Roslyn Jaffe Food Allergy Institute   (United States)

Author keywords

anaphylaxis; food allergens; Food allergy; food hypersensitivity; peanut allergy; treatment

Indexed keywords

ADRENALIN; ALLERGEN; ANTACID AGENT; ANTIBIOTIC AGENT; FAHF 2; HERBACEOUS AGENT; IMMUNOGLOBULIN E ANTIBODY; OLIGODEOXYNUCLEOTIDE DERIVATIVE; OMALIZUMAB; PEPTIDE; PLASMID DNA; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VACCINE;

ALLERGIC REACTION; CHINESE HERB; CLINICAL OBSERVATION; CLINICAL STUDY; CLINICAL TRIAL; CROSS REACTION; DIAGNOSTIC TEST; DISEASE COURSE; EPIDEMIC; EXPOSURE; FOOD CONTAMINATION; GENETIC ANALYSIS; HERBAL MEDICINE; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; INTROSPECTION; MATERNAL NUTRITION; NONHUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PEANUT; PEANUT ALLERGY; PRIORITY JOURNAL; RESEARCH; REVIEW;

ALLERGENS; ANIMALS; ARACHIS HYPOGAEA; DIET; FEMALE; HUMANS; MATERNAL EXPOSURE; PEANUT HYPERSENSITIVITY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PREVALENCE;

EID: 34548238214     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.07.015     Document Type: Review

References (143)

1. Sicherer S.H., Muñoz-Furlong A., and Sampson H.A. Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: a 5-year follow-up study. J Allergy Clin Immunol 112 (2003) 1203-1207
2. Grundy J., Matthews S., Bateman B., Dean T., and Arshad S.H. Rising prevalence of allergy to peanut in children: data from 2 sequential cohorts. J Allergy Clin Immunol 110 (2002) 784-789
3. Kagan R.S., Joseph L., Dufresne C., Gray-Donald K., Turnbull E., Pierre Y.S., et al. Prevalence of peanut allergy in primary-school children in Montreal, Canada. J Allergy Clin Immunol 112 (2003) 1223-1228
4. Hourihane J.O., Aiken R., Briggs R., Gudgeon L.A., Grimshaw K.E., Dunngalvin A., et al. The impact of government advice to pregnant mothers regarding peanut avoidance on the prevalence of peanut allergy in United Kingdom children at school entry. J Allergy Clin Immunol 119 (2007) 1197-1202
5. Hourihane J.O., Roberts S.A., and Warner J.O. Resolution of peanut allergy: case-control study. BMJ 316 (1998) 1271-1275
6. Skolnick H.S., Conover-Walker M.K., Koerner C.B., Sampson H.A., Burks W., and Wood R.A. The natural history of peanut allergy. J Allergy Clin Immunol 107 (2001) 367-374
7. Bock S.A., Munoz-Furlong A., and Sampson H.A. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 107 (2001) 191-193
8. Bock S.A., Munoz-Furlong A., and Sampson H.A. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol 119 (2007) 1016-1018
9. Pumphrey R.S., and Gowland M.H. Further fatal allergic reactions to food in the United Kingdom, 1999-2006. J Allergy Clin Immunol 119 (2007) 1018-1019
10. Flinterman A.E., Pasmans S.G., Hoekstra M.O., Meijer Y., Van Hoffen E., Knol E.F., et al. Determination of no-observed-adverse-effect levels and eliciting doses in a representative group of peanut-sensitized children. J Allergy Clin Immunol 117 (2006) 448-454
11. Primeau M.N., Kagan R., Joseph L., Lim H., Dufresne C., Duffy C., et al. The psychological burden of peanut allergy as perceived by adults with peanut allergy and the parents of peanut-allergic children. Clin Exp Allergy 30 (2000) 1135-1143
12. Cohen B.L., Noone S., Munoz-Furlong A., and Sicherer S.H. Development of a questionnaire to measure quality of life in families with a child with food allergy. J Allergy Clin Immunol 114 (2004) 1159-1163
13. Yu J.W., Kagan R., Verreault N., Nicolas N., Joseph L., St Pierre Y., et al. Accidental ingestions in children with peanut allergy. J Allergy Clin Immunol 118 (2006) 466-472
14. Sicherer S.H. Clinical update on peanut allergy. Ann Allergy Asthma Immunol 88 (2002) 350-361
15. Sampson H.A. Clinical practice. Peanut allergy. N Engl J Med 346 (2002) 1294-1299
16. Woods R.K., Abramson M., Bailey M., and Walters E.H. International prevalences of reported food allergies and intolerances. Comparisons arising from the European Community Respiratory Health Survey (ECRHS) 1991-1994. Eur J Clin Nutr 55 (2001) 298-304
17. Morisset M., Moneret-Vautrin D.A., and Kanny G. Prevalence of peanut sensitization in a population of 4,737 subjects: an Allergo-Vigilance Network enquiry carried out in 2002. Allerg Immunol (Paris) 37 (2005) 54-57
18. Osterballe M., Hansen T.K., Mortz C.G., Host A., and Bindslev-Jensen C. The prevalence of food hypersensitivity in an unselected population of children and adults. Pediatr Allergy Immunol 16 (2005) 567-573
19. Dalal I., Binson I., Reifen R., Amitai Z., Shohat T., Rahmani S., et al. Food allergy is a matter of geography after all: sesame as a major cause of severe IgE-mediated food allergic reactions among infants and young children in Israel. Allergy 57 (2002) 362-365
20. Shek L.P., and Lee B.W. Food allergy in Asia. Curr Opin Allergy Clin Immunol 6 (2006) 197-201
21. Santadusit S., Atthapaisalsarudee S., and Vichyanond P. Prevalence of adverse food reactions and food allergy among Thai children. J Med Assoc Thai 88 suppl 8 (2005) S27-S32
22. Wong G.W., Hui D.S., Chan H.H., Fok T.F., Leung R., Zhong N.S., et al. Prevalence of respiratory and atopic disorders in Chinese schoolchildren. Clin Exp Allergy 31 (2001) 1225-1231
23. Sicherer S.H., and Sampson H.A. Food allergy. J Allergy Clin Immunol 117 suppl 2 (2006) S470-S475
24. Leung T.F., Lam C.W., Chan I.H., Li A.M., and Tang N.L. Sensitization to common food allergens is a risk factor for asthma in young Chinese children in Hong Kong. J Asthma 39 (2002) 523-529
25. Wang J., Visness C.M., and Sampson H.A. Food allergen sensitization in inner-city children with asthma. J Allergy Clin Immunol 115 (2005) 1076-1080
26. Bashir M.E., Louie S., Shi H.N., and Nagler-Anderson C. Toll-like receptor 4 signaling by intestinal microbes influences susceptibility to food allergy. J Immunol 172 (2004) 6978-6987
27. Kull I., Bergstrom A., Melen E., Lilja G., van Hage M., Pershagen G., et al. Early-life supplementation of vitamins A and D, in water-soluble form or in peanut oil, and allergic diseases during childhood. J Allergy Clin Immunol 118 (2006) 1299-1304
28. Camargo C.A., Clark S., Kaplan M., Lieberman P., and Wood R.A. Regional differences in EpiPen prescriptions in the United States: the potential role of vitamin D. J Allergy Clin Immunol 120 (2007) 131-136
29. Kull I., Bergstrom A., Lilja G., Pershagen G., and Wickman M. Fish consumption during the first year of life and development of allergic diseases during childhood. Allergy 61 (2006) 1009-1015
30. Untersmayr E., Poulsen L.K., Platzer M.H., Pedersen M.H., Boltz-Nitulescu G., Skov P.S., et al. The effects of gastric digestion on codfish allergenicity. J Allergy Clin Immunol 115 (2005) 377-382
31. Sicherer S.H., Furlong T.J., Maes H.H., Desnick R.J., Sampson H.A., and Gelb B.D. Genetics of peanut allergy: a twin study. J Allergy Clin Immunol 106 (2000) 53-56
32. Shreffler W.G., Charlop-Powers Z., and Sicherer S.H. Lack of association of HLA class II alleles with peanut allergy. Ann Allergy Asthma Immunol 96 (2006) 865-869
33. American Academy of Pediatrics. Committee on Nutrition. Hypoallergenic infant formulas. Pediatrics 106 (2000) 346-349
34. Tariq S.M., Stevens M., Matthews S., Ridout S., Twiselton R., and Hide D.W. Cohort study of peanut and tree nut sensitisation by age of 4 years. BMJ 313 (1996) 514-517
35. Levy Y., Broides A., Segal N., and Danon Y.L. Peanut and tree nut allergy in children: role of peanut snacks in Israel?. Allergy 58 (2003) 1206-1207
36. Dean T., Venter C., Pereira B., Grundy J., Clayton C.B., and Higgins B. Government advice on peanut avoidance during pregnancy: is it followed correctly and what is the impact on sensitization?. J Hum Nutr Diet 20 (2007) 95-99
37. Strid J., Thomson M., Hourihane J., Kimber I., and Strobel S. A novel model of sensitization and oral tolerance to peanut protein. Immunol 113 (2004) 293-303
38. Omata N., Ohshima Y., Yasutomi M., Yamada A., Karasuyama H., and Mayumi M. Ovalbumin-specific IgE modulates ovalbumin-specific T-cell response after repetitive oral antigen administration. J Allergy Clin Immunol 115 (2005) 822-827
39. de Jonge J.D., Knippels L.M., Ezendam J., Odink J., Penninks A.H., and van Loveren H. The importance of dietary control in the development of a peanut allergy model in Brown Norway rats. Methods 41 (2007) 99-111
40. Rowe J., Kusel M., Holt B.J., Suriyaarachchi D., Serralha M., Hollams E., et al. Prenatal versus postnatal sensitization to environmental allergens in a high-risk birth cohort. J Allergy Clin Immunol 119 (2007) 1164-1173
41. Boyle R.J., and Tang M.L. Can allergic diseases be prevented prenatally?. Allergy 61 (2006) 1423-1431
42. Liem J.J., Kozyrskyj A.L., Huq S.I., and Becker A.B. The risk of developing food allergy in premature or low-birth-weight children. J Allergy Clin Immunol 119 (2007) 1203-1209
43. Maleki S.J., Viquez O., Jacks T., Dodo H., Champagne E.T., Chung S.Y., et al. The major peanut allergen, Ara h 2, functions as a trypsin inhibitor, and roasting enhances this function. J Allergy Clin Immunol 112 (2003) 190-195
44. Pomes A., Butts C.L., and Chapman M.D. Quantification of Ara h 1 in peanuts: why roasting makes a difference. Clin Exp Allergy 36 (2006) 824-830
45. Beyer K., Morrow E., Li X.M., Bardina L., Bannon G.A., Burks A.W., et al. Effects of cooking methods on peanut allergenicity. J Allergy Clin Immunol 107 (2001) 1077-1081
46. Kopper R.A., Odum N.J., Sen M., Helm R.M., Stanley J.S., and Burks A.W. Peanut protein allergens: the effect of roasting on solubility and allergenicity. Int Arch Allergy Immunol 136 (2005) 16-22
47. Hinds M.J., Beuchat L.R., and Chinnan M.S. Effects of homogenization pressure and stabilizers on some physical characteristics of a beverage prepared from partially defatted, roasted peanuts. Plant Foods Hum Nutr 50 (1997) 269-277
48. Mouecoucou J., Fremont S., Sanchez C., Villaume C., and Mejean L. In vitro allergenicity of peanut after hydrolysis in the presence of polysaccharides. Clin Exp Allergy 34 (2004) 1429-1437
49. Lack G., and Golding J. Peanut and nut allergy: reduced exposure might increase allergic sensitisation. [letter]. BMJ 313 (1996) 300
50. Lack G., Fox D., Northstone K., and Golding J. Factors associated with the development of peanut allergy in childhood. N Engl J Med 348 (2003) 977-985
51. Klemola T., Kalimo K., Poussa T., Juntunen-Backman K., Korpela R., Valovirta E., et al. Feeding a soy formula to children with cow's milk allergy: the development of immunoglobulin E-mediated allergy to soy and peanuts. Pediatr Allergy Immunol 16 (2005) 641-646
52. Pons L., Ponnappan U., Hall R.A., Simpson P., Cockrell G., West C.M., et al. Soy immunotherapy for peanut-allergic mice: modulation of the peanut-allergic response. J Allergy Clin Immunol 114 (2004) 915-921
53. Hsieh K.Y., Tsai C.C., Wu C.H., and Lin R.H. Epicutaneous exposure to protein antigen and food allergy. Clin Exp Allergy 33 (2003) 1067-1075
54. Mortz C.G., Andersen K.E., and Bindslev-Jensen C. The prevalence of peanut sensitization and the association to pollen sensitization in a cohort of unselected adolescents: the Odense Adolescence Cohort Study on Atopic Diseases and Dermatitis (TOACS). Pediatr Allergy Immunol 16 (2005) 501-506
55. Mittag D., Akkerdaas J., Ballmer-Weber B.K., Vogel L., Wensing M., Becker W.M., et al. Ara h 8, a Bet v 1-homologous allergen from peanut, is a major allergen in patients with combined birch pollen and peanut allergy. J Allergy Clin Immunol 114 (2004) 1410-1417
56. Sicherer S.H., and Bock S.A. An expanding evidence base provides food for thought to avoid indigestion in managing difficult dilemmas in food allergy. J Allergy Clin Immunol 117 (2006) 1419-1422
57. Arbes Jr. S.J., Gergen P.J., Elliott L., and Zeldin D.C. Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey. J Allergy Clin Immunol 116 (2005) 377-383
58. Sampson H.A., and Ho D.G. Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents. J Allergy Clin Immunol 100 (1997) 444-451
59. Sampson H.A. Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol 107 (2001) 891-896
60. Perry T.T., Matsui E.C., Kay Conover-Walker M., and Wood R.A. The relationship of allergen-specific IgE levels and oral food challenge outcome. J Allergy Clin Immunol 114 (2004) 144-149
61. Sporik R., Hill D.J., and Hosking C.S. Specificity of allergen skin testing in predicting positive open food challenges to milk, egg and peanut in children. Clin Exp Allergy 30 (2000) 1541-1546
62. Roberts G., and Lack G. Diagnosing peanut allergy with skin prick and specific IgE testing. J Allergy Clin Immunol 115 (2005) 1291-1296
63. Pucar F., Kagan R., Lim H., and Clarke A.E. Peanut challenge: a retrospective study of 140 patients. Clin Exp Allergy 31 (2001) 40-46
64. Ho M.H., Heine R.G., Wong W., and Hill D.J. Diagnostic accuracy of skin prick testing in children with tree nut allergy. J Allergy Clin Immunol 117 (2006) 1506-1508
65. Wainstein B.K., Yee A., Jelley D., Ziegler M., and Ziegler J.B. Combining skin prick, immediate skin application and specific-IgE testing in the diagnosis of peanut allergy in children. Pediatr Allergy Immunol 18 (2007) 231-239
66. Rance F., Abbal M., and Lauwers-Cances V. Improved screening for peanut allergy by the combined use of skin prick tests and specific IgE assays. J Allergy Clin Immunol 109 (2002) 1027-1033
67. Nolan R.C., Richmond P., Prescott S.L., Mallon D.F., Gong G., Franzmann A.M., et al. Skin prick testing predicts peanut challenge outcome in previously allergic or sensitized children with low serum peanut-specific IgE antibody concentration. Pediatr Allergy Immunol 18 (2007) 224-230
68. Savage J.H., Limb S.L., Brereton N.H., and Wood R.A. The natural history of peanut allergy-extending our knowledge beyond childhood. J Allergy Clin Immunol 120 (2007) 717-719
69. Ronteltap A., van Schaik J., Wensing M., Rynja F.J., Knulst A.C., and de Vries J.H. Sensory testing of recipes masking peanut or hazelnut for double-blind placebo-controlled food challenges. Allergy 59 (2004) 457-460
70. Fleischer D.M., Conover-Walker M.K., Christie L., Burks A.W., and Wood R.A. The natural progression of peanut allergy: resolution and the possibility of recurrence. J Allergy Clin Immunol 112 (2003) 183-189
71. Busse P.J., Nowak-Wegrzyn A.H., Noone S.A., Sampson H.A., and Sicherer S.H. Recurrent peanut allergy. N Engl J Med 347 (2002) 1535-1536
72. Fleischer D.M., Conover-Walker M.K., Christie L., Burks A.W., and Wood R.A. Peanut allergy: recurrence and its management. J Allergy Clin Immunol 114 (2004) 1195-1201
73. Flinterman A.E., Knulst A.C., Meijer Y., Bruijnzeel-Koomen C.A., and Pasmans S.G. Acute allergic reactions in children with AEDS after prolonged cow's milk elimination diets. Allergy 61 (2006) 370-374
74. Hourihane J.O., Grimshaw K.E., Lewis S.A., Briggs R.A., Trewin J.B., King R.M., et al. Does severity of low-dose, double-blind, placebo-controlled food challenges reflect severity of allergic reactions to peanut in the community?. Clin Exp Allergy 35 (2005) 1227-1233
75. Perry T.T., Matsui E.C., Conover-Walker M.K., and Wood R.A. Risk of oral food challenges. J Allergy Clin Immunol 114 (2004) 1164-1168
76. Grimshaw K.E., King R.M., Nordlee J.A., Hefle S.L., Warner J.O., and Hourihane J.O. Presentation of allergen in different food preparations affects the nature of the allergic reaction: a case series. Clin Exp Allergy 33 (2003) 1581-1585
77. Simons F., Frew A.J., Ansotegui I.J., Bochner B., Golden D.B., Finkelman F.D., et al. Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol 120 (2007) S1-S24
78. Peeters K.A., Koppelman S.J., Van Hoffen E., van der Tas C.W., Hartog Jager C.F., Penninks A.H., et al. Does skin prick test reactivity to purified allergens correlate with clinical severity of peanut allergy?. Clin Exp Allergy 37 (2007) 108-115
79. Palmer G.W., Dibbern Jr. D.A., Burks A.W., Bannon G.A., Bock S.A., Porterfield H.S., et al. Comparative potency of Ara h 1 and Ara h 2 in immunochemical and functional assays of allergenicity. Clin Immunol 115 (2005) 302-312
80. Astier C., Morisset M., Roitel O., Codreanu F., Jacquenet S., Franck P., et al. Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergy. J Allergy Clin Immunol 118 (2006) 250-256
81. Lewis S.A., Grimshaw K.E., Warner J.O., and Hourihane J.O. The promiscuity of immunoglobulin E binding to peanut allergens, as determined by Western blotting, correlates with the severity of clinical symptoms. Clin Exp Allergy 35 (2005) 767-773
82. Shreffler W.G., Beyer K., Chu T.H., Burks A.W., and Sampson H.A. Microarray immunoassay: association of clinical history, in vitro IgE function, and heterogeneity of allergenic peanut epitopes. J Allergy Clin Immunol 113 (2004) 776-782
83. Sampson H.A., Muñoz-Furlong A., Campbell R.L., Adkinson Jr. N.F., Bock S.A., Branum A., et al. Second symposium on the definition and management of anaphylaxis: summary report: Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 117 (2006) 391-397
84. Beyer K., Bardina L., Grishina G., and Sampson H.A. Identification of four major sesame seed allergens by 2D-proteonomics and Edman sequencing: seed storage proteins as common food allergens. J Allergy Clin Immunol 109 (2002) S288
85. de Leon M.P., Drew A.C., Glaspole I.N., Suphioglu C., O'Hehir R.E., and Rolland J.M. IgE cross-reactivity between the major peanut allergen Ara h 2 and tree nut allergens. Mol Immunol 44 (2007) 463-471
86. Wensing M., Knulst A.C., Piersma S., O'Kane F., Knol E.F., and Koppelman S.J. Patients with anaphylaxis to pea can have peanut allergy caused by cross-reactive IgE to vicilin (Ara h 1). J Allergy Clin Immunol 111 (2003) 420-424
87. Sicherer S.H., and Sampson H.A. Peanut and tree nut allergy. Curr Opin Pediatr 12 (2000) 567-573
88. Peeters K.A., Nordlee J.A., Penninks A.H., Chen L., Goodman R.E., Bruijnzeel-Koomen C., et al. Lupine allergy: not simply cross-reactivity with peanut or soy. J Allergy Clin Immunol 120 (2007) 647-653
89. Moneret-Vautrin D.A., Guerin L., Kanny G., Flabbee J., Fremont S., and Morisset M. Cross-allergenicity of peanut and lupine: the risk of lupine allergy in patients allergic to peanuts. J Allergy Clin Immunol 104 (1999) 883-888
90. Guarneri F., Guarneri C., and Benvenga S. Identification of potentially cross-reactive peanut-lupine proteins by computer-assisted search for amino acid sequence homology. Int Arch Allergy Immunol 138 (2005) 273-277
91. Clark A.T., and Ewan P.W. The development and progression of allergy to multiple nuts at different ages. Pediatr Allergy Immunol 16 (2005) 507-511
92. Taylor S.L., Hefle S.L., Bindslev-Jensen C., Bock S.A., Burks Jr. A.W., Christie L., et al. Factors affecting the determination of threshold doses for allergenic foods: how much is too much?. J Allergy Clin Immunol 109 (2002) 24-30
93. Wensing M., Penninks A.H., Hefle S.L., Koppelman S.J., Bruijnzeel-Koomen C.A., and Knulst A.C. The distribution of individual threshold doses eliciting allergic reactions in a population with peanut allergy. J Allergy Clin Immunol 110 (2002) 915-920
94. Hourihane J.O., Kilburn S.A., Nordlee J.A., Hefle S.L., Taylor S.L., and Warner J.O. An evaluation of the sensitivity of subjects with peanut allergy to very low doses of peanut protein: a randomized, double-blind, placebo-controlled food challenge study. J Allergy Clin Immunol 100 (1997) 596-600
95. Leung D.Y., Sampson H.A., Yunginger J.W., Burks Jr. A.W., Schneider L.C., Wortel C.H., et al. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med 348 (2003) 986-993
96. Hefle S.L., Furlong T.J., Niemann L., Lemon-Mule H., Sicherer S.H., and Taylor S.L. Consumer attitudes and risks associated with packaged goods having advisory labeling regarding the presence of peanuts. J Allergy Clin Immunol 120 (2007) 171-176
97. Simonte S.J., Ma S., Mofidi S., and Sicherer S.H. Relevance of casual contact with peanut butter in children with peanut allergy. J Allergy Clin Immunol 112 (2003) 180-182
98. Perry T.T., Conover-Walker M.K., Pomes A., Chapman M.D., and Wood R.A. Distribution of peanut allergen in the environment. J Allergy Clin Immunol 113 (2004) 973-976
99. Maloney J.M., Chapman M.D., and Sicherer S.H. Peanut allergen exposure through saliva: assessment and interventions to reduce exposure. J Allergy Clin Immunol 118 (2006) 719-724
100. Sampson M.A., Munoz-Furlong A., and Sicherer S.H. Risk-taking and coping strategies of adolescents and young adults with food allergy. J Allergy Clin Immunol 117 (2006) 1440-1445
101. Arnold D.M., Blajchman M.A., Ditomasso J., Kulczycki M., and Keith P.K. Passive transfer of peanut hypersensitivity by fresh frozen plasma. Arch Intern Med 167 (2007) 853-854
102. Hourihane J.O., Rhodes H.L., Jones A.M., Veys P., and Connett G.J. Resolution of peanut allergy following bone marrow transplantation for primary immunodeficiency. Allergy 60 (2005) 536-537
103. Koppelman S.J., Knol E.F., Vlooswijk R.A., Wensing M., Knulst A.C., Hefle S.L., et al. Peanut allergen Ara h 3: isolation from peanuts and biochemical characterization. Allergy 58 (2003) 1144-1151
104. de Leon M.P., Rolland J.M., and O'Hehir R.E. The peanut allergy epidemic: allergen molecular characterisation and prospects for specific therapy. Expert Rev Mol Med 9 (2007) 1-18
105. Rabjohn P., Helm E.M., Stanley J.S., West C.M., Sampson H.A., Burks A.W., et al. Molecular cloning and epitope analysis of the peanut allergen Ara h 3. J Clin Invest 103 (1999) 535-542
106. Restani P., Ballabio C., Corsini E., Fiocchi A., Isoardi P., Magni C., et al. Identification of the basic subunit of Ara h 3 as the major allergen in a group of children allergic to peanuts. Ann Allergy Asthma Immunol 94 (2005) 262-266
107. Koppelman S.J., Vlooswijk R.A., Knippels L.M., Hessing M., Knol E.F., Van Reijsen F.C., et al. Quantification of major peanut allergens Ara h 1 and Ara h 2 in the peanut varieties Runner, Spanish, Virginia, and Valencia, bred in different parts of the world. Allergy 56 (2001) 132-137
108. Chung S.Y., Butts C.L., Maleki S.J., and Champagne E.T. Linking peanut allergenicity to the processes of maturation, curing, and roasting. J Agric Food Chem 51 (2003) 4273-4277
109. Chung S.Y., and Champagne E.T. Allergenicity of Maillard reaction products from peanut proteins. J Agric Food Chem 47 (1999) 5227-5231
110. Mondoulet L., Paty E., Drumare M.F., Ah-Leung S., Scheinmann P., Willemot R.M., et al. Influence of thermal processing on the allergenicity of peanut proteins. J Agric Food Chem 53 (2005) 4547-4553
111. Maleki S.J., Chung S.Y., Champagne E.T., and Raufman J.P. The effects of roasting on the allergenic properties of peanut proteins. J Allergy Clin Immunol 106 (2000) 763-768
112. Audibert F., and Chedid L. [Increase of immune response by administration of metabolizable vegetable oil emulsions]. C R Acad Sci Hebd Seances Acad Sci D 280 (1975) 1629-1632
113. Shreffler W.G., Castro R.R., Kucuk Z.Y., Charlop-Powers Z., Grishina G., Yoo S., et al. The major glycoprotein allergen from Arachis hypogaea, Ara h 1, is a ligand of dendritic cell-specific ICAM-grabbing nonintegrin and acts as a Th2 adjuvant in vitro. J Immunol 177 (2006) 3677-3685
114. Meyer S., van Liempt E., Imberty A., van Kooyk Y., Geyer H., Geyer R., et al. DC-SIGN mediates binding of dendritic cells to authentic pseudo-LewisY glycolipids of Schistosoma mansoni cercariae, the first parasite-specific ligand of DC-SIGN. J Biol Chem 280 (2005) 37349-37359
115. Turcanu V., Maleki S.J., and Lack G. Characterization of lymphocyte responses to peanuts in normal children, peanut-allergic children, and allergic children who acquired tolerance to peanuts. J Clin Invest 111 (2003) 1065-1072
116. Thottingal T.B., Stefura B.P., Simons F.E., Bannon G.A., Burks W., and HayGlass K.T. Human subjects without peanut allergy demonstrate T cell-dependent, TH2-biased, peanut-specific cytokine and chemokine responses independent of TH1 expression. J Allergy Clin Immunol 118 (2006) 905-914
117. Shin D.S., Compadre C.M., Maleki S.J., Kopper R.A., Sampson H., Huang S.K., et al. Biochemical and structural analysis of the IgE binding sites on ara h1, an abundant and highly allergenic peanut protein. J Biol Chem 273 (1998) 13753-13759
118. Stanley J.S., King N., Burks A.W., Huang S.K., Sampson H., Cockrell G., et al. Identification and mutational analysis of the immunodominant IgE binding epitopes of the major peanut allergen Ara h 2. Arch Biochem Biophys 342 (1997) 244-253
119. Beyer K., Ellman-Grunther L., Jarvinen K.M., Wood R.A., Hourihane J., and Sampson H.A. Measurement of peptide-specific IgE as an additional tool in identifying patients with clinical reactivity to peanuts. J Allergy Clin Immunol 112 (2003) 202-207
120. Shreffler W.G., Lencer D.A., Bardina L., and Sampson H.A. IgE and IgG4 epitope mapping by microarray immunoassay reveals the diversity of immune response to the peanut allergen, Ara h 2. J Allergy Clin Immunol 116 (2005) 893-899
121. Oppenheimer J.J., Nelson H.S., Bock S.A., Christensen F., and Leung D.Y.M. Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol 90 (1992) 256-262
122. Chehade M., and Mayer L. Oral tolerance and its relation to food hypersensitivities. J Allergy Clin Immunol 115 (2005) 3-12
123. Patriarca G., Nucera E., Roncallo C., Pollastrini E., Bartolozzi F., De Pasquale T., et al. Oral desensitizing treatment in food allergy: clinical and immunological results. Aliment Pharmacol Ther 17 (2003) 459-465
124. Patriarca G., Nucera E., Pollastrini E., De Pasquale T., Lombardo C., Buonomo A., et al. Oral rush desensitization in peanut allergy: a case report. Dig Dis Sci 51 (2006) 471-473
125. Mansfield L. Successful oral desensitization for systemic peanut allergy. Ann Allergy Asthma Immunol 97 (2006) 266-267
126. Nash S.D., Steele P.H., Kamilaris S.J., Pons L., Kulis M., Lee A., et al. Oral peanut immunotherapy for peanut allergic patients. J Allergy Clin Immunol 119 (2007) S158
127. Enrique E., Pineda F., Malek T., Bartra J., Basagana M., Tella R., et al. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol 116 (2005) 1073-1079
128. Meglio P., Bartone E., Plantamura M., Arabito E., and Giampietro P.G. A protocol for oral desensitization in children with IgE-mediated cow's milk allergy. Allergy 59 (2004) 980-987
129. Rolinck-Werninghaus C., Staden U., Mehl A., Hamelmann E., Beyer K., and Niggemann B. Specific oral tolerance induction with food in children: transient or persistent effect on food allergy?. Allergy 60 (2005) 1320-1322
130. Sampson H.A., Leung D.Y.M., Burks A.W., Lack G., Bahna S.L., Jones S.M., et al. A phase II, randomized, double-blind, parallel group, placebo-controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy. J Allergy Clin Immun 119 (2007) S117
131. Li X.M., Schofield B.H., Huang C.K., Kleiner G.I., and Sampson H.A. A murine model of IgE-mediated cow's milk hypersensitivity. J Allergy Clin Immunol 103 (1999) 206-214
132. Li X.M., Serebrisky D., Lee S.Y., Huang C.K., Bardina L., Schofield B.H., et al. A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses. J Allergy Clin Immunol 106 (2000) 150-158
133. Li X.M., Zhang T.F., Huang C.K., Srivastava K., Teper A.A., Zhang L., et al. Food Allergy Herbal Formula-1 (FAHF-1) blocks peanut-induced anaphylaxis in a murine model. J Allergy Clin Immunol 108 (2001) 639-646
134. Srivastava K.D., Kattan J.D., Zou Z.M., Li J.H., Zhang L., Wallenstein S., et al. The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy. J Allergy Clin Immunol 115 (2005) 171-178
135. Qu C., Srivastava K., Ko J., Zhang T.F., Sampson H.A., and Li X.M. Induction of tolerance after establishment of peanut allergy by the food allergy herbal formula-2 is associated with up-regulation of interferon-gamma. Clin Exp Allergy 37 (2007) 846-855
136. Bannon G.A., Cockrell G., Connaughton C., West C.M., Helm R., Stanley J.S., et al. Engineering, characterization and in vitro efficacy of the major peanut allergens for use in immunotherapy. Int Arch Allergy Immunol 124 (2001) 70-72
137. Li X.M., Srivastava K., Grishin A., Huang C.K., Schofield B., Burks W., et al. Persistent protective effect of heat-killed Escherichia coli producing "engineered," recombinant peanut proteins in a murine model of peanut allergy. J Allergy Clin Immunol 112 (2003) 159-167
138. Nowak-Wegrzyn A., and Sampson H.A. Food allergy therapy. Immunol Allergy Clin North Am 24 (2004) 705-725
139. Raz E., Tighe H., Sato Y., Corr M., Dudler J.A., Roman M., et al. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci U S A 93 (1996) 5141-5145
140. Li X., Huang C.K., Schofield B.H., Burks A.W., Bannon G.A., Kim K.H., et al. Strain-dependent induction of allergic sensitization caused by peanut allergen DNA immunization in mice. J Immunol 162 (1999) 3045-3052
141. Roy K., Mao H.Q., Huang S.K., and Leong K.W. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 5 (1999) 387-391
142. Creticos P.S., Chen Y.H., and Schroeder J.T. New approaches in immunotherapy: allergen vaccination with immunostimulatory DNA. Immunol Allergy Clin North Am 24 (2004) 569-581
143. Nguyen M.D., Cinman N., Yen J., and Horner A.A. DNA-based vaccination for the treatment of food allergy. Allergy 56 suppl 67 (2001) 127-130